drugset / Trial / NCT02070965
DFD01 Spray vs Comp01 Lotion HPA Axis Suppression Study in Patients With Moderate to Severe Plaque Psoriasis
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the potential of DFD01 spray to suppress the HPA (hypothalamic-pituitary-adrenal) axis as compared to Comp01 lotion when applied twice daily for 15 days.
Timeline
- Start
- 2014-01
- Primary completion
- 2014-10
- Completion
- 2014-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Comp01 | Unknown | 0.05 % | — |
| Subject | betamethasone dipropionate | Small molecule | 0.05 % | Topical |